Sign in

CIK 0001762303

  • Non-accelerated filer
  • Smaller reporting company

AVITA Medical, Inc.

Sign in to watch
Tickers
RCEL AVHHL
Exchange
Nasdaq, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202578762
Phone
+1 661-568-1317
Business address
28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
Former names
Avita Therapeutics, Inc., Avita Medical, Ltd.

Securities

  • RCEL Common Stock Nasdaq
  • AVHHL Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy CFO bought 975 shares at an average $12.46 ($12,152)
  3. 4 Grant or award Director acquired 10,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 9,200 shares (grant or award)
  6. 4 Grant or award Director acquired 9,200 shares (grant or award)
  7. 4 Grant or award Director acquired 9,200 shares (grant or award)
  8. 4 Grant or award Director acquired 9,200 shares (grant or award)
  9. 4 Grant or award Director acquired 9,200 shares (grant or award)
  10. 4 Grant or award Director acquired 9,200 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award General Counsel acquired 2,225 shares (grant or award)
  13. 4 Open-market buy CFO bought 1,000 shares at an average $8.90 ($8,900)
  14. 4 Open-market buy CFO bought 1,250 shares at an average $17.39 ($21,738)
  15. 4 Grant or award General Counsel acquired 1,469 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale CEO sold 1,445 shares at $13.29 ($19,204)
  18. 4/A Open-market sale Director sold 2,500 shares at $12.49 ($31,225)
  19. 4 Open-market sale Director sold 2,518 shares at $12.27 ($30,896)
  20. 4 Open-market buy CFO bought 950 shares at $12.45 ($11,828)

Page 3 of 7 · 140 filings